High Court bans 34 pharmaceutical companies from producing medicines
Staff Correspondent, bdnews24.com
Published: 2017-02-13 14:47:07.0 BdST Updated: 2017-02-14 02:15:50.0 BdST
Twenty pharmaceutical companies have been banned from producing all medicines and 14 others from producing antibiotics by the High Court.
The order on Monday by Justices Syed Mohammed Dastagir and Ataur Rahman Khan came after hearing of a rule issued earlier on a petition filed by the Human Rights and Peace for Bangladesh (HRPB) to stop production and marketing of substandard medicines.
The order asked the Bangladesh drug regulatory authority to regularly monitor whether these companies continued to produce and market medicines and file a report to the High Court after every four months.
HRPB counsel Manzill Murshid said that the government has already cancelled the license of 7-8 of these 34 companies.
The High Court has constituted a five-member committee to examine fresh application by those companies who have not had their license cancelled, if they agreed to abide by existing drug regulatory parameters.
The committee consists of a representative each from World Health Organisation, Bangladesh Drug Regulatory Authority, Dhaka University's Pharmacy department and the Health Ministry.
Twenty companies banned from producing all medicines
Exim Pharmaceuticals, Avert Pharma Ltd, Bikalpa Pharmaceuticals Ltd, Dolphin Pharmaceuticals Ltd, Drugland Ltd, Globe Laboratories Pvt Ltd, Jolpa Laboratories Ltd, Kafma Pharmaceuticals Ltd, Medico Pharmaceuticals Ltd, National Drug Pharma Ltd, North Bengal Pharmaceuticals Ltd, Rimo Chemicals Ltd, Rid Pharmaceuticals Ltd, Skylab Pharmaceuticals Ltd, Spark Pharmaceuticals Ltd, Star Pharmaceuticals Ltd, Shunipun Pharmaceuticals Ltd, Today Pharmaceuticals Ltd, Tropical Pharmaceuticals Ltd and Universal Pharmaceuticals Ltd
Fourteen companies banned from producing antibiotics
Ad-dwin Pharmaceutical Ltd, Alkad Laboratories Ltd, Belsen Pharmaceuticals Ltd, Bengal Drugs and Chemicals (Pharma) Ltd, Bristol Pharma Ltd, Crystal Pharmaceuticals Ltd, Indo-Bangla Pharmaceuticals Ltd, Millat Pharmaceuticals Ltd, MST Pharma and Healthcare Ltd, Orbit Pharmaceuticals Ltd, Pharmic Laboratories ltd, Phoenix Chemical Laboratory Ltd, Rasa Pharmaceuticals Ltd and Save Pharmaceuticals Ltd
Any unauthorised use or reproduction of bdnews24.com content for commercial purposes is strictly prohibited and constitutes copyright infringement liable to legal action.
- Rangs chief Rouf, HRC Chairman Sayeed cleared of 1996 share fraud
- Grameenphone earns Tk 6.6bn in net profit in the first quarter
- PRAN appoints cricketer Taskin Atom Gum brand ambassador
- Almost half of Rana Plaza survivors are still jobless: Report
- Finance Minister Muhith takes up GP's dropped calls to Telenor chief
- Asian stocks climb, euro surrenders gains as French election jitters return
- EU eyes years of Brexit payments, immigration – document
- Retailers not paying much for products from green factories, minister says
- Global stocks struggle as French elections loom, North Korea worries
- Bangladesh Bank eases rules for IT service exporters
- Bangladesh, Poland agree to work on migration and maritime economy sectors
- Jatiya Party presidium member Bablu marries Ershad’s niece
- Lightning kills five in Bangladesh coastal districts
- India 'relaxes' loan conditions for Bangladesh, Finance Minister Muhith says
- ISPR dismisses Times of India report on Indian Army chief's Dhaka visit as 'baseless'
- Signal No. 3 hoisted at ports due to bad weather, rain may continue
- Man burns himself in attempted suicide during altercation with 'girlfriend'
- Initial tests reveal radiation in Sunamganj backswamps not alarming
- Moosa gets two weeks to appear before customs over seizure of car
- Death toll in Dinajpur rice mill boiler blast rises to nine